Research
Neural
Nose-to-brain (N2B) pathways can address limitations of the subcutaneous route for GLP-1 RAs.
Practitioners should explore N2B pathways as a viable alternative for delivering GLP-1 RAs.
StrongSupportsmedium confidence
Nose-to-brain (N2B) pathways can address limitations of the subcutaneous route for GLP-1 RAs.
Why this rating
The abstract discusses the potential of N2B pathways based on existing literature.
Source
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges
Tanisha Tabassum Sayka Khan et al. · Expert Opinion on Drug Delivery · 2024
DOI 10.1080/17425247.2024.2387110
reviewCited 12×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Neural
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →